Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Cognistat is not a typical general-purpose SaaS product, but a cognitive screening and assessment tool designed for medical settings. It is used to quickly test for cognitive deficits such as delirium, mild cognitive impairment (MCI), and dementia, and is applicable to adolescents aged 12–19, adults aged 20–59, and older adults aged 60–84. The tool must be administered by trained healthcare professionals; patients cannot self-test.
Its core function is domain-specific cognitive assessment: five cognitive domains—language, spatial skills, memory, calculations, and reasoning—are scored separately. The original version takes around 15–20 minutes to complete, while Cognistat Five takes about 5 minutes and is aimed at rapid screening for MCI, delirium, and dementia. The computer-assisted version can record and automatically evaluate responses, and presents results graphically, making annual follow-up comparisons easier. Deployment options include a paper-and-pencil version, the web-based CAS-II, and the stand alone offline Active Form; Cognistat Five is also available in both web and offline versions.
The website discloses pricing for the paper version: Starter Kit at $575, manual at $75, stimulus book at $35, 50 test booklets at $750, 25 test booklets at $475, and so on, with English and Spanish options available. The main content does not disclose subscription or licensing fees for the web-based or offline software versions, nor does it mention a free trial. In terms of support, the website says it provides online training videos and clinical support, and cites more than 400 peer-reviewed publications as its evidence base.
Its advantages are clear clinical positioning, a mature testing workflow, and broad applicability across scenarios, making it suitable for assessments in neuropsychology, rehabilitation, geriatric medicine, nursing homes, traumatic brain injury, sports concussion, and more. Patients do not need to operate a computer, which also makes it convenient for telehealth interviews. The limitation is that it is more of a professional medical assessment product than an open enterprise SaaS platform: there is no disclosed API, EHR/EMR integration, team permission management, data security compliance, or audit mechanisms. Interpreting its diagnostic significance still requires a medical or psychological professional background.
Cognistat is better suited to hospitals, clinics, rehabilitation institutions, nursing homes, and neuropsychology or geriatric medicine teams for standardized cognitive screening, annual follow-ups, and pre-/post-treatment comparisons. The main content does not state whether access from China, network stability, or payment availability is supported, so these remain unknown. If local deployment, Chinese-language scales, or integration with medical insurance or hospital information systems is required, MoCA, MMSE, and domestic medical IT alternatives can also be evaluated.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on cognistat.com official site.
cognistat.com is an United States Health provider. TG4G tracks its product information, an overall rating of 8.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach cognistat.com directly.